Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

NCT00684307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1084

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonvalvular Atrial Fibrillation

Interventions

DRUG: AZD0837
DRUG: Vitamin-K antagonist at INR 2-3
DRUG: AZD0837

Sponsor

AstraZeneca